SCHEMBL6969688

SCHEMBL6969688

CN(Cc1ccc(Cl)cc1)C(=O)N(C)Cc1ccc(CCc2c[nH]cn2)cc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
HTT P42858 1/20 0.46
RAB9A P51151 1/20 0.46
NPC1 O15118 1/20 0.39
DAO P14920 1/20 0.37
P2RX7 Q99572 4/20 0.37
KDM4E B2RXH2 2/20 0.37
TSHR P16473 1/20 0.37
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
AKT1 P31749 1/20 0.34
AKT2 P31751 1/20 0.34
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
THRB P10828 1/20 0.34
AOC3 Q16853 1/20 0.34
LSS P48449 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6971987 0.95 ALDH1A1 (0.42) ALDH1A1HTTRAB9ANPC1DAO
SCHEMBL6961731 0.89 ALDH1A1 (0.49) ALDH1A1HTTRAB9ANPC1DAO
SCHEMBL6966618 0.89 ALDH1A1 (0.47) ALDH1A1HTTRAB9ANPC1P2RX7
SCHEMBL6969265 0.87 ALDH1A1 (0.41) ALDH1A1HTTRAB9ANPC1P2RX7
SCHEMBL9024637 0.84 ALDH1A1 (0.37) ALDH1A1HTTRAB9ANPC1DAO
SCHEMBL9078864 0.84 ALDH1A1 (0.37) ALDH1A1HTTRAB9ANPC1DAO
SCHEMBL9024045 0.82 AOC3 (0.41) ALDH1A1HTTRAB9ANPC1P2RX7
SCHEMBL224352 0.82 DAO (0.41) ALDH1A1HTTDAOTSHRKMT2A
SCHEMBL6973527 0.82 LTB4R (0.46) ALDH1A1HTTRAB9AAOC3
SCHEMBL6970199 0.78 RAB9A (0.40) ALDH1A1HTTRAB9ANPC1P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729459-B1 PHENYL-ALKYL IMIDAZOLES AS H3-RECEPTOR ANTAGONISTS SCHERING CORP (US) 2003-03-12 EP disclosed
US-5578616-A ANTIINFLAMMATORY AGENTS, ANTIALLERGENS, TREATMENT FOR GASTROINTESTINAL AND CARDIOVASCULAR DISORDERS SCHERING CORPORATION (US) 1996-11-26 US disclosed